Vives Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 41
  • Portfolio
  • 16
  • Exits
  • 10
Exits

Vives General Information

Description

Founded in 2004, Vives is a seed capital venture fund based in Louvain-la-Neuve, Belgium that prefers to invest in spin-offs and start-ups. The firm seeks to invest in the mobile, sport and high technology sectors.

Contact Information

Year Founded
2004
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • Place de l'Université 16 bte 27
  • 1348 Louvain-la-Neuve
  • Belgium
+32 010 00 00 00

Vives Investments (41)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ViroVet 04-Jun-2020 Early Stage VC 00.00 Drug Discovery Generating Revenue 00000 00000000 00.0
0-0000 01-Jun-2020 00000 00000 00.000 Application Specific Semiconductors Generating Revenue
00000 000000000000 24-Mar-2020 00000 00000 00000 Drug Discovery Pre-Clinical Trials 00000000 0000000
00000 000000000000 24-Apr-2019 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 00000000 0000000
0000000 09-Jan-2019 00000 00000 00.000 Biotechnology Generating Revenue
00000000 07-Jan-2019 00000 00000 00000 Electronics (B2C) Generating Revenue
0-000000 0000000 27-Apr-2018 00000 00000 0000 Biotechnology Generating Revenue
00000000 22-Mar-2018 00000 00000 00000 Business/Productivity Software Generating Revenue
Syndesi Therapeutics 01-Feb-2018 Early Stage VC 000.00 Drug Discovery Startup 00000 00000000 00.0
Axinesis 13-Dec-2017 Early Stage VC 00000 Therapeutic Devices Generating Revenue 0000é 00000000000000000
You’re viewing 10 of 41 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vives Exits (10)

Company Name Exit Date Exit Type Exit Size
iTeos Therapeutics 24-Jul-2020 IPO 00000
0000000000 01-Jul-2019 000000000000000000
000000000 10-Jan-2018 000000000000000000
000000000 09-Sep-2016 000000000000000000
00000000 24-Feb-2016 0000000000: 000000
000000000 08-Jan-2015 0000000000
0000000 10-Oct-2012 00000000 000000 00
0-0000000 00000000 27-Sep-2012 000000000000000000
Alterface Secondary Transaction - Private
Viridaxis Secondary Transaction - Private
To view Vives’s complete exits history, request access »

Vives Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Vives Team (11)

Name Title Deals Funds Boards Office
Michèle Hody Ph.D Patent Manager Louvain-la-Neuve, Belgium
Mélanie Lecomte Patent Manager & Legal Advisor Louvain-la-Neuve, Belgium
Yannick Vancoppenolle Senior Business & Investment manager Louvain-la-Neuve, Belgium
Pascale Sinaï Chief Financial Officer Louvain-la-Neuve, Belgium
Philippe Durieux Managing Director 00 0 0 Louvain-la-Neuve, Belgium
You’re viewing 5 of 11 team members. Get the full list »